Today: 29 April 2026
Browse Category

NYSE:CHPT 16 September 2025 - 17 December 2025

EV Stocks Today (Dec. 17, 2025): Tesla’s California Autopilot Case, Ford’s $6.5B Battery Deal Exit, and Fresh Catalysts for EVgo, QuantumScape, Rivian, and Lucid

EV Stocks Today (Dec. 17, 2025): Tesla’s California Autopilot Case, Ford’s $6.5B Battery Deal Exit, and Fresh Catalysts for EVgo, QuantumScape, Rivian, and Lucid

Tesla shares fell 2.5% to $477.59 by midday after California’s DMV paused a 30-day suspension of the company’s sales and manufacturing licenses over “Autopilot” marketing. Ford dropped 2.1% after scrapping a major battery supply deal. Rivian and QuantumScape rose 1.3% and 3%, respectively. Broader EV stocks moved on regulatory and policy headlines.
17 December 2025
·············
EV Stocks Weekly Recap: Tesla’s China Bounce, Rivian Recall and Policy Shockwaves Rock the Sector (Dec 1–7, 2025)

EV Stocks Weekly Recap: Tesla’s China Bounce, Rivian Recall and Policy Shockwaves Rock the Sector (Dec 1–7, 2025)

U.S. EV sales collapsed in early December, hitting Ford and other legacy automakers after federal tax credits ended. Tesla posted rare sales growth in China and broke records in Norway, but cut prices again in Europe. Rivian recalled 35,000 vehicles, while Chinese EV makers reported strong deliveries but saw shares fall. Charging stocks slumped on warnings of weaker demand.
7 December 2025
········
ChargePoint Stock (CHPT) Jumps Over 20% After Q3 Earnings: Outlook, Analyst Price Targets and Risks

ChargePoint Stock (CHPT) Jumps Over 20% After Q3 Earnings: Outlook, Analyst Price Targets and Risks

ChargePoint shares jumped 22% to $10.43 on December 5 after reporting fiscal Q3 2026 revenue of $105.7 million, up 6.1% year-over-year and beating estimates. The company narrowed its net loss to $52.5 million and improved gross margin to 31%. Trading volume reached $25.5 million. The stock remains well below its 52-week high despite the rally.
6 December 2025
···
ChargePoint (CHPT) Stock After Q3 2026 Earnings: Debt Deal, Target Cut and What’s Next for the EV Charging Leader

ChargePoint (CHPT) Stock After Q3 2026 Earnings: Debt Deal, Target Cut and What’s Next for the EV Charging Leader

ChargePoint reported Q3 FY2026 revenue of $105.7 million, up 6% year-over-year, with GAAP net loss narrowing to $52.5 million. The company cut $172 million in debt and extended maturities to 2030. Shares closed at $8.50 on December 4, still down 60% year-to-date. RBC Capital lowered its price target to $9, maintaining a “Reduce”/“Hold” consensus.
5 December 2025
···
ChargePoint (CHPT) Stock Surges After Q3 FY 2026 Earnings Beat and $172 Million Debt Cut – Is a Turnaround Under Way?

ChargePoint (CHPT) Stock Surges After Q3 FY 2026 Earnings Beat and $172 Million Debt Cut – Is a Turnaround Under Way?

ChargePoint reported Q3 FY 2026 revenue of $105.7 million, up 6% year over year, and cut its total debt by $172 million in November. Gross margin reached a record 33% non‑GAAP, while net loss narrowed 32% to $52.5 million. Shares closed at $8.52 on December 4, then jumped about 10% in after-hours trading. The stock remains down roughly 60–65% for the year.
5 December 2025
···
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Helios vs. Tesla: Inside the Solar-Powered EV Charging Platform Shaking Up the Industry

Helios Charging launched an online platform in September 2025 to connect accredited investors with U.S. EV charging and solar projects, offering tax credit-backed returns. The company manages the full project lifecycle and focuses on solar-powered charging. Helios enters a market led by Tesla, ChargePoint, EVgo, and Electrify America, each with distinct business models and scale. Helios finances infrastructure through investor capital, targeting 8–12% returns.
16 September 2025
···

Stock Market Today

  • Nasdaq Futures Rise Ahead of Fed Decision and Major Tech Earnings
    April 29, 2026, 9:10 AM EDT. Nasdaq futures gained 0.4% ahead of the Federal Reserve's policy decision and earnings reports from tech giants Alphabet, Microsoft, Amazon, and Meta. Markets are cautious following a broad sell-off in major indices driven by chip stock weakness linked to slowing growth at AI firm OpenAI. Investors await the Fed's stance on inflation and interest rates, with crude oil prices rising amid unresolved US-Iran tensions. The Fed is expected to hold rates steady in Jerome Powell's final meeting before his replacement, Kevin Warsh, awaits Senate approval. Key focus remains on AI capital expenditure and the potential for further rate hikes in 2024. Earnings from AbbVie, AstraZeneca, Total Energies, UBS, and GSK are also in focus.

Latest article

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Humana Stock Drops After Earnings Beat: Medicare Advantage Headwind Keeps Pressure On

Humana Stock Drops After Earnings Beat: Medicare Advantage Headwind Keeps Pressure On

29 April 2026
Humana beat first-quarter profit estimates, earning $10.31 per share adjusted, but shares fell over 6% premarket after it kept its 2026 profit outlook unchanged and cut its GAAP earnings forecast. Revenue rose to $39.65 billion. The insurer cited lower Medicare Star Ratings for the earnings decline and said medical and pharmacy costs are “slightly better” than expected. Competitors Centene, UnitedHealth, and Elevance recently raised their annual forecasts.
Go toTop